Myelofibrosis in 2019: moving beyond JAK2 inhibition

Michael Schieber, John D. Crispino, Brady Stein*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

34 Scopus citations


Dive into the research topics of 'Myelofibrosis in 2019: moving beyond JAK2 inhibition'. Together they form a unique fingerprint.

Agricultural and Biological Sciences

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science